Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)

NCT05092139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-03-18

No results posted yet for this study

Summary

This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

Conditions

  • Stroke, Ischemic

Interventions

DEVICE

endovascular treatment

all enrolled patients must receive endovascular treatment

Sponsors & Collaborators

  • General Hospital of Shenyang Military Region

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-21
Primary Completion
2025-01-10
Completion
2025-01-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05092139 on ClinicalTrials.gov